drugset / Trial / NCT03113396

Baclofen for Rumination

NCT03113396

Phase 4 Completed 20 enrolled Universitaire Ziekenhuizen KU Leuven
RandomizedCrossoverTriple-blindTreatment

Summary

Patients with a clinical suspicion of rumination syndrome and/or supra-gastric belching are randomized into baclofen or placebo for 2 weeks (10mg, tid). thereafter, they undergo a high resolution impedance manometry measurement, were they receive a solid meal, and recordings continue for another hour. Thereafter, they will receive the alternative treatment, after which they will undergo a second high resolution impedance manometry measurement. Patients are asked to fill out questionnaires during the entire study period.

Timeline

Start
2012-02-01
Primary completion
2016-12-31
Completion
2016-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Baclofen Small molecule 10 mg Oral